Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Gastroenterology
•
Advanced Endoscopy
What do you consider an optimal interval of time to repeat necrosectomies for treatment of WON?
What evidence do you use to guide this decision-making?
Related Questions
What factors influence your choice of EMR vs ESD vs FTR for gastric neoplastic lesions?
Which patients would benefit from pancreatic duct stents in combination with rectal indomethacin for prophylaxis against post-ERCP pancreatitis?
Do you routinely use single-use duodenoscopes for ERCPs in patients with a history of infections secondary to MDR organisms?
Do you feel there is any difference between performing an ERCP with an EDGE together in a single session or separately in two sessions in a patient with Roux-en-Y anatomy?
How would active Crohn's on Adalimumab affect the adjuvant management of a T2aN0M0 gallbladder cancer?
How do you approach managing nausea and GI side effects when initiating methotrexate?
Is there a role for use of dupilumab for hypereosinophilic GI disorders distal to the esophagus?
When and how should we use biomarkers (i.e., CRP, stool calprotectin, mAb levels) to guide or optimize medical management of Crohn’s disease or ulcerative colitis?
Do you avoid JAK inhibitors in patients with a history of liver disease including NAFLD or cirrhosis?
What pharmacologic therapies do you use to treat alcohol use disorder in a patient with cirrhosis?